News 7 March 2024 VStrong Incyte 2023 Inguinity awards winner Wow, what incredible news! The selection committee has awarded the… Marketing 0 Love0
News 8 December 2023 Vitiligo and Us Comic Book The French Vitiligo Association is delighted to unveil its inaugural… Marketing 0 Love0
News 23 November 2023 Doctors’ training on vitiligo in the D.R.C The Association Franco-Congolaise du Vitiligo (AFCV), which was created in… Marketing 0 Love0
- Study phase 2 Abbvie -UPADACITINIBNews 20 October 2023 Upadacitinib Meets Primary End Point of Phase 2 Trial for Vitiligo and Advances to Phase 3 AbbVie recently announced that its phase 2b study investigating upadacitinib (Rinvoq)… Marketing 0 Love0
News 18 May 2023 New therapy for vitiligo patients For a long time, vitiligo was considered purely a cosmetic… VIPOC 0 Love0
News 22 April 2023 Incyte Announces European Commission Approval Of Opzelura® (Ruxolitinib) Cream For The Treatment Of Non-Segmental Vitiligo With Facial Involvement In Adults And Adolescents April 20, 2023 at 10:21 AM EDT Opzelura® (ruxolitinib) Cream is… VIPOC 0 Love0
News 3 March 2023 The first step for a medicinal product for vitiligo has been authorized in Europe On February 23, 2023, the European Medicines Agency (EMA) published… VIPOC 0 Love0
News 9 June 2022 3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS) 50 attendees - 20 nations 20 leaders of vitiligo organizations… VIPOC 0 Love0